Endothelial Progenitor Cells Derived from mESCs Were Directed to Differentiate into Vascular Endothelial Cells and Promote Wound Healing
10.13865/j.cnki.cjbmb.2022.02.1515
- Author:
Feng-Jiao CHEN
1
;
Zhao-Yan ZUO
1
;
Jia-Hui LV
1
;
Ying YANG
1
;
Liu YANG
1
;
Jie DING
1
;
Qian PENG
2
;
Ying LU
3
Author Information
1. Key Laboratory of Plant Resource Conservation and Germplasm Innovation in Mountainous Region (Ministry of Education), CollaborativeInnovation Center for Mountain Ecology and Agro-Bioengineering (CICMEAB), College of Life Sciences, Institute of Agro-bioengineering, Guizhou University
2. Shanghai lnstitute of Nutrition and Health, University of Chinese Academy ofScience
3. Department of Anatomy, School of Basic Medicine, Guizhou University of Traditional Chinese Medicine
- Publication Type:Journal Article
- Keywords:
angiogenesis;
endothelial progenitor cells (EPCs);
mouse embryonic stem cells (mESCs);
vascularendothelial cells (VECs);
wound healing
- From:
Chinese Journal of Biochemistry and Molecular Biology
2022;38(3):320-332
- CountryChina
- Language:Chinese
-
Abstract:
Ischemic dysfunction is an important global health problem. Vascular endothelial cells(VECs) play a key role in angiogenesis, and insufficient vascular remodeling may lead to chronic nonhealing wounds. Therefore, effective VEC generation strategies of exploration help improve angiogenesisin damaged tissues. Embryonic stem cells (ESCs) are widely used in the study of tissueendothelialization, and endothelial progenitor cells (EPCs) are indispensable parts of the development ofVECs. The aims of this study were to find a rapid, easily screened and reproducible method for thederivation of EPCs from mouse embryonic stem cells (mESCs), and obtain VECs with high survival ratesand strong functions from the directed differentiation of the EPCs. The results showed that mESCs weredifferentiated into " stepping stone" -like progenitor cells with active proliferative ability by 10 ng / mLVEGF and 5 ng / mL bFGF. At the same time, the method of differential adherence was helpful for theselection of EPCs, and EPCs induced high expression of CD133 and CD34 (The relative expressionlevels were 0. 88 ± 0. 04 and 2. 12 ± 0. 02, respectively) for 3 days. Then EPCs were digested withacctuse enzymes, and induced to differentiate into vascular endothelial-like cells by 50 ng / mL VEGF and25 ng / mL bFGF for 7 days. The endothelial cells not only expressed endothelial marker genes (CD31, CD144, LAMA5, Tek, KDR and vWF),and marker proteins CD31, CD144 and LAMA5 (The relativeexpression levels were 1. 07 ± 0. 03, 0. 60 ± 0. 02 and 0. 70 ± 0. 02, respectively), but also had thegood ability of migration, tubulogenesis and formation of W-P bodies. Moreover, PBS, EPC and VECwere used to treat wounds of the same size. Both EPC and VEC could accelerate the degree of tissuehealing (The relative healing rates were 78. 93 ± 75. 35%, 95. 57 ± 83. 73% and 100. 00 ± 0. 00%, respectively), and VEC significantly enhanced the ability of wound angiogenesis and inflammatoryresponses. In consequence, this study preliminarily confirmed that mESC-derived EPCs coulddifferentiate into VECs after directional induction for 7 days, which had good function of tissue repair. The physiological pathway on stem cells by stimulating angiogenesis is expected to become a new target fortissue remodeling.
